All posts by admin

Sacramento’s Cannabis Industry Ensnared in Expanding Campaign Finance Investigation

Sacramento’s Cannabis Industry Ensnared in Expanding Campaign Finance Investigation

Andrey Kukushkin, one of four businessmen indicted last week in a complex campaign finance investigation, is an officer at THC in Sacramento, according to reporting by Theresa Clift, Dale Kasler and Ryan Sabalow at the Sacramento Bee

Kukushkin is one of two named permit holders for THC, and he is the CFO of a company called Sharp Source, which, according to the Bee, owns THC. (As far as the business, THC stands for Twelve Hour Care.)

Garib Karapetyan is also named on the THC permit; he holds another seven cannabis retail dispensaries in Sacramento. The city allows a maximum of 30 cannabis retail storefronts.

The Bee points out that there is no overt connection between the funding for Karaptyan’s cannabis businesses and the broader campaign finance scheme detailed in a federal indictment—yet.

Broadly speaking, the investigation has targeted a cohort of foreign-born U.S. businessmen diverting international funds into U.S. political campaigns, including to Nevada politicians who may have been in a position to assist the four indicted men with cannabis business licensing in that state. The web of investigations is closely linked with the ongoing presidential impeachment inquiry in Washington, D.C., including the men’s ties to President Trump’s personal attorney, Rudy Giuliani.

Read the full Sacramento Bee story here.

Now that the campaign finance investigation has reeled in Kukushkin, the network of shared ownership interests in Sacramento’s cannabis market is under a microscope. Sacramento Mayor Darrell Steinberg has called for an investigation into Karapetyan’s consolidation of ownership in Sacramento’s cannabis market—and Kukushkin’s involvement.

“If this story is true, then our cannabis licensing process, which was designed to protect consumers and reward local law-abiding businesses, is being improperly exploited,” spokeswoman Mary Lynne Vellinga said in a public statement. “The mayor is calling for an immediate investigation and will lead an effort to add additional safeguards to the licensing process.”

Two sets of questions are raised here.

One is local: How did Karaptyan come to hold so many of the city’s cannabis dispensaries? And how is the city just now coming to realize the degree of ownership consolidation? What was Kukushkin’s involvement in the Sacramento businesses?

The other set of questions is an international concern: What is the extent of the campaign finance investigation’s inroads into the U.S. cannabis industry? Who else is involved?

Chris Kudialis at Leafly took a stab at the latter, detailing the misadventures of the four businessmen and their attempts at manipulating elections in Nevada to tilt the cannabis licensing process in their favor. Kukushkin, who already had a foothold in the California cannabis industry, played a visible role in this scheme.

andrey kukushkin cannabis industry ukraine campaign finance

According to the unsealed indictment in the Southern District of New York, Kukushkin was actively involved in funneling foreign cash into the 2018 gubernatorial race in Nevada, though he’d admitted to his fellow campaign finance violators that they were “two months too late to the game unless we change the rules,” referring to Nevada’s licensing deadlines last year. The businessmen sought to elect a Republican governor who could then nudge forward legislative amendments to Nevada’s cannabis law. Adam Laxalt, the Republican candidate in question, went on to lose the November 2018 election.

Read the full indictment below. The cannabis information begins at the bottom of page 10.

Along with the four businessmen, an unnamed “Foreign National 1” is listed in the indictment as the benefactor of this cannabis industry campaign finance scheme.

Mother Jones has connected a few dots and put forth an educated guess as to who Foreign National 1 might be—namely, a Russian businessman named Andrey Muraviev, who created a cannabis company in California with none other than Kukushkin and Karapetyan. The three men started a business called Legacy Botanical Company LLC, the license for which has since been suspended by the state of California. Muraviev’s role in the broader campaign finance investigation is as yet unconfirmed.

Nonetheless, after all of that, it’s clear that the campaign finance violations unfolding alongside the impeachment inquiry into Trump’s political dealings in Ukraine have at least some sort of connection to the cannabis industry. As this story develops, we’ll continue to track just how it all fits together.

U.S. v. Parnas et al by sandydocs on Scribd

Published at Mon, 14 Oct 2019 19:28:00 +0000

MedMen-PharmaCann Acquisition Falls Apart, New Report Says Vaping-Related Illnesses Similar to Chemical Burns: Week in Review

MedMen-PharmaCann Acquisition Falls Apart, New Report Says Vaping-Related Illnesses Similar to Chemical Burns: Week in Review

TORONTO–(BUSINESS WIRE)–PRESS RELEASE–FSD Pharma Inc. has announced the appointment of former U.S. Congressman Stephen Buyer to the company’s Board of Directors. The company also announced that it will complete a consolidation of its class A multiple voting shares and its class B subordinate voting shares, each on a 1 to 201 basis.

“In welcoming Steve Buyer to the FSD Pharma Board of Directors and announcing a share consolidation, the company has made an immense positive stride forward” said Raza Bokhari, MD, executive co-chairman and CEO. “Steve’s addition has further strengthened the independence and profile of the FSD Pharma Board of Directors; his broad leadership experience and pharmaceutical industry relationships will help enhance our visibility, especially among U.S. Institutional investors and on U.S. Capitol Hill. The share consolidation or reverse split of our stock is timed to advance our strategic plan to raise the profile of our company in the U.S. capital markets, which includes listing on a major U.S. stock exchange in the near future.”

“I’m pleased to be joining the FSD Pharma Board of Directors. The opportunity to participate in FSD’s growth at this stage is exciting. Unfortunately, auto immune diseases have clustered in my wife’s family. I am attracted by FSD’s medical research to tame and define the unknown by challenging the edges of medical science to provide relief to people suffering from fibromyalgia and other serious illnesses,” stated Buyer.

Stephen Buyer was a member of the United States House of Representatives, serving nine consecutive terms from January 1993 to January 2011. During Congressman Buyer’s long tenure in the Congress, he served on the Committees on Veterans Affairs, Armed Services, Judiciary, Energy and Commerce Committees and also served on the Military Compensation and Retirement Modernization Commission. He is presently the Managing Partner of the 10-Square Solution, LLC, focusing on business development, mergers and acquisitions, and representation before the federal government.

Congressman Buyer served as Chairman of the Committee on Veterans Affairs for the 109th Congress, as well as the Ranking Minority Member for the 110th and 111th Congresses. He centralized the VA’s IT architecture and was named to the Federal IT top 100. Congressman Buyer also served on the House Armed Services Committee from 1993 to 2001, including as Chair of the Subcommittee on Military Personnel in the 105th and 106th Congresses. He founded and co-chaired the National Guard and Reserve Components Caucus. He created the renewable energy portfolio for the Department of Defense and Veteran Affairs. He was the architect of TRICARE For Life and authored the U.S. military’s pharmacy redesign. His other Congressional assignments included service on the Health, Energy, and Technology subcommittees of the Committee on Energy and Commerce from 2001 to 2010, where he assisted in creating Medicare Part D, authored the electronic pedigree pharmaceuticals distribution system, served as a House Conferee on the Telecommunications Act of 1996, and lead the Congressional effort to reorganization of the U.S. Olympic Committee. He also served the House Committee on Judiciary from 1993 to 1999.

Congressman Buyer, as an Army Reserve officer, served four years on active duty, including a tour of duty in Iraq during the first Gulf War (1990-91) where he was awarded the Bronze Star as an Operational Law Judge Advocate. Prior to JAG, he was a Medical Service Corps Officer for four years. Congressman Buyer, after 30 years of service, retired with the rank of Colonel in the U.S. Army Reserve Judge Advocate General Corps.

Prior to his tenure in the United States Congress, Congressman Buyer served as a Special Assistant United States Attorney, Indiana Deputy Attorney General, and engaged in a private law practice.

Congressman Buyer is a distinguished military graduate of The Citadel in 1980 with a B.S. degree, and received his J.D. from Valparaiso University School of Law in 1984. He is a member of the Indiana and Virginia state Bars.

In addition, FSD is pleased to announce that its Board of Directors has approved the Consolidation on a 1:201 basis. Effective Oct. 16, 2019, with a record date of Oct. 17, 2019, the company expects to begin trading the Class B Shares on the Canadian Securities Exchange on a post-Consolidation basis under its existing name and ticker symbol. The new CUSIP and ISIN for the Class B Shares are 35954B206 and CA35954B2066, respectively.

The company currently has 1,582,966,252 Class B Shares outstanding and the consolidation will reduce the issued and outstanding Class B Shares to approximately 7,874,809 Class B Shares. The consolidation was approved by FSD shareholders at the company’s special meeting held on Jan. 22, 2019, and will allow the company to continue to pursue the listing of the Class B Shares on a major U.S. exchange.

The company will not be issuing fractional post-Consolidation FSD Shares in connection with the Consolidation. Where the consolidation would otherwise result in a shareholder being entitled to a fractional FSD Share, the number of post-consolidation FSD Shares issued to such holder of FSD Shares shall be rounded down to the nearest whole number of FSD Shares. In calculating such fractional interests, all FSD Shares held by a beneficial shareholder shall be aggregated.

A letter of transmittal with respect to the consolidation will be mailed to registered shareholders of the company. All registered shareholders with physical certificates will be required to send their certificates representing pre-Consolidation FSD Shares along with a completed letter of transmittal to the company’s transfer agent, Computershare Investor Services Inc., in accordance with the instructions provided in the letter of transmittal. Additional copies of the letter of transmittal can be obtained through Computershare. All shareholders who submit a duly completed letter of transmittal along with their pre-Consolidation FSD share certificate(s) to Computershare will receive a post-Consolidation share certificate. Shareholders who hold their FSD Shares through a broker or other intermediary and do not have FSD Shares registered in their name will not need to complete a letter of transmittal.

The exercise or conversion price and the number of FSD Shares issuable under any of the company’s outstanding warrants and stock options will be proportionately adjusted to reflect the consolidation in accordance with the respective terms thereof. After the consolidation, there will be approximately 1,033,782 stock options and warrants to purchase 576,499 Class B Shares outstanding.

The Class A Shares will also be consolidated on a 1:201 basis, such that post-consolidation there will be 72 Class A Shares issued and outstanding, each Class A Share representing 276,660 votes on all matters. Based on the current issued and outstanding number of FSD Shares, the Class A Shares collectively represent approximately 72 percent of the voting rights.

Published at Sat, 12 Oct 2019 14:00:00 +0000

Vapen MJ President and CFO Bob Brilon to Present at Upcoming Investor Conferences

Vapen MJ President and CFO Bob Brilon to Present at Upcoming Investor Conferences

Vapen MJ (OTCQX:VAPNF; CSE:VAPN) (“Vapen MJ”) a fully integrated manufacturer and distributor of cannabis THC and hemp CBD products under the Vapen Brand, leveraging core expertise in extraction and marketing to build wholesale distribution through revenue and profit sharing partnerships, announced today that Bob Brilon, President and CFO will be presenting at the following conferences in October.

The Microcap Rodeo

  • Presentation date and time: Tuesday, October 15 at 3:50 pm CT with management hosting one-on-one meetings the same day
  • Location: Hilton Austin, Austin, TX
  • For more information visit the conference website: https://microcaprodeo.com

Benzinga Cannabis Capital Conference

  • Presentation date and time: Wednesday, October 23 at 2:20pm CT with management hosting one-on-one meetings the same day
  • Location: Palmer House, Chicago, IL
  • For more information visit the conference website and use code VAPENVIP for 20% off admission: https://benzingacannabisconference.com/chicago/

For more information on Vapen MJ, please visit our websites at www.VapenMJ.com or www.VapenCBD.com.

About Vapen MJ Ventures

Vapen MJ, through its wholly-owned subsidiaries, currently operates in the US as an agricultural technology, services and property management company utilizing a full vertical integration business model to oversee and execute all aspects of cultivation, extraction, manufacturing (THC and CBD cartridges, concentrates, edibles), retail dispensary, and wholesale distribution of high margin Cannabis THC and Hemp CBD products under the Vapen Brand. Vapen MJ expansion includes partnering with cannabis license holders and hemp farms in multiple states within the US.

Forward Looking Statements
We Seek Safe Harbour.

Cision

View original content:http://www.prnewswire.com/news-releases/bob-brilon-vapen-mj-president-and-cfo-to-present-at-upcoming-investor-conferences-300936920.htmlSOURCE Vapen MJ Ventures Corporation

Copyright (c) 2019 PR Newswire Association,LLC. All Rights Reserved.

Published at Fri, 11 Oct 2019 13:05:23 +0000

ENDEXX ORD (OTCMKTS:EDXC) To Open Approximately 5000 Stores Nationwide

ENDEXX ORD (OTCMKTS:EDXC) To Open Approximately 5000 Stores Nationwide

ENDEXX ORD (OTCMKTS:EDXC),
now CBD Unlimited, today stated its pivotal strategic initiatives. The CEO of
the company, Todd Davis, says it was impressive for the company to have
surpassed the set year-end target. The plan was to set up about 5,000 retail
stores, and despite a few challenges, this has been achieved.

Steps to reach company goals

Davis opined, “With energetic determination, we continue to see tremendous growth in demand, both nationally and internationally. Our focus remains with our consumers and stakeholders as we continue to expand our product reach.”

The
official added that they were in talks with some other leading retailers to discuss
ways to enhance business. Market observers have also commented, saying that
indeed, the company has ramped up its business operations at an exponential
rate. They have also congratulated the company for hitting its set target three
months before the targeted time.

When
the demand for superior CBD products surged, CBD Unlimited, with immediate
effect, knew more work was to be done. That is why it took to set up a robust
pilot program. It made this announcement in mid-July 2019. In the near term,
the business giant hopes to have established between 8,000-10,000 stores.

CBD
Unlimited says it will continue doing its best to become one of the leading
contributors to the dynamic industry. It states that in the previous year it
increased its stores by 500%. This percentage represents a rise in the store
count from 1000 to about 5000 or even more.

Focus into the future

CBD
Unlimited says it won’t hesitate to take up any business growth opportunity
that might present itself. The CBD market is booming at the moment. This
business sees the roll-out plans as its ticket to generating higher revenues.

The
5000 figure comprises of some 4000 plus Major Drug and Grocery Outlets and 300
convenient stores. The remaining 1000 has Wellness centers, Doctor’s offices,
independent retail stores, and Vet and Animal care facilities.

CBD
Unlimited has several long-term goals. However, the most outstanding is
marketing and selling its products on a wider scale. The company hopes to
increase its customers, even on a global scale.

Published at Wed, 09 Oct 2019 12:42:40 +0000

MJardin Receives Full Purchase Price from Joint Venture Partner, Begins Phase 2 Development at its Largest Cultivation Facility

MJardin Receives Full Purchase Price from Joint Venture Partner, Begins Phase 2 Development at its Largest Cultivation Facility

LOS ANGELES, Oct. 7, 2019 /PRNewswire/ — PRESS RELEASE — Viola, a producer and retailer of premium quality cannabis products founded by NBA veteran Al Harrington, has announced the closing of a $16 million funding round led by Gotham Green Partners. The investment firm, known for its financial support of some of the most reputable cannabis companies in the industry, is the first institutional investment in the company.

This latest round of funding will assist with the acquisition of a 34,500-square-foot cultivation, processing and distribution facility in Adelanto, Calif., as well as the completion of Viola’s 48,000-square-foot facility in Detroit, Mich. The funds will also enable Viola to continue to advance the growth of the company’s personnel with key new hires that will continue to establish Viola as a leader in the cannabis marketplace.

Viola emerged on the scene with a commitment to making an impact by promoting social equity through increasing minority participation in the cannabis industry and positively impacting communities by reinvesting in individuals most affected by the war on drugs. Viola raised $15 million prior to this round of funding, which enabled the company to grow its product offerings and footprint within the cannabis industry. The company is currently operating in California, Colorado, Oregon and Michigan, with plans to expand into Maryland, Nevada and Arizona in 2020.

“Over the last five years, Viola has been dedicated to creating and producing quality herbal experiences for our customers,” said Harrington, CEO of Viola. “With the financial support and investment of Gotham Green Partners, our ability to dedicate more physical space to growing and cultivating our flowers and team will make the possibilities endless.” 

“We are thrilled to be aligned with Viola as the company expands its lifestyle brand into new markets,” said Jason Adler, managing member of Gotham Green Partners. “As the firm’s visionary, Al has successfully launched the concept and subsequently surrounded himself with a top-notch management team. Further, Al’s background and the company’s mission resonate with a broad and engaged consumer base, and we are excited to see Viola products on more retail shelves across the country.”

Published at Tue, 08 Oct 2019 19:23:00 +0000

Puration Inc (OTCMKTS:PURA) Projects Its 2019 CBD Beverage Sales Target

Puration Inc (OTCMKTS:PURA) Projects Its 2019 CBD Beverage Sales Target

Puration Inc (OTCMKTS:PURA)
has remained a top seller of EVERx CBD Sports Water for quite a while now. The
company’s CEO Brian Shibley says they are moving into a European Distribution
Agreement for their leading product.

The agreement and what it entails

He
released the details about the agreement through a presentation and said the
company might generate high revenues. According to him, they might even make $4
on an annual basis. The presentation was conducted at the Arnold Sports
Festival in Barcelona.

Some
shareholders have been piling pressure on the company to disclose the
distributor the company is collaborating with. So far, it remains a mystery for
them since the business guru hasn’t named the distributor yet.

PURA faces pressure to name its new
distributor

 PURA hasn’t yet announced the distributor
doesn’t mean it is going to keep it a secret forever. Meanwhile, it needs to
look out for the interests of its new clients and partners. The problem is that
an early announcement usually results in new clients and partners receiving
some unsolicited calls. Most of them are not welcoming of such calls, and the
company should protect them.

The
company has also revealed the findings from a research body known as Goldman
Small Cap. This researcher had been entrusted with carrying out a CBD beverage
industry survey on behalf of the company and is already through with the
process. PURA says it will soon unveil the information collected from the
survey. The business guru usually conducts such surveys to help enhance
existing products or introducing new ones. The plan at the moment is to launch
new CBD infused coffee, beer, and tea beverages.

PURA
also intends to publish updates of its new coffee infused with CBD as well as
the unveiling of TranquiliTeaCBD. It also knows that the shareholders are eager
to know the company’s progress update. In this regard, it intends to provide
more information about the 2019 $4 million sales milestone.

Over
the past six months, the company has already managed to generate about $1
million in CBD beverage sales. In the previous year, it generated about $1
million as well. The new milestone seems high, but only time will tell.

Published at Tue, 08 Oct 2019 13:40:03 +0000

Aleafia Health Completes Construction, Secures Full Occupancy at Paris Processing Facility Expansion

Aleafia Health Completes Construction, Secures Full Occupancy at Paris Processing Facility Expansion

Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) has completed the construction of its Paris Processing facility’s Phase II expansion and secured full site occupancy on October 4, 2019, following the successful completion of County of Brant inspections. The Paris Phase II expansion is a 30,000 sq. ft. facility entirely dedicated to the extraction, production, packaging and distribution of high-margin, value-added cannabis health and wellness products.

The expansion builds upon the current, licensed and operational Paris facility, which features cultivation rooms and handles all extraction, packaging and order fulfillment for Aleafia Health’s medical, adult-use and international sales.

Paris will feature an initial 115,000 kg dried flower equivalent (“DFE”) extraction capacity, a 2,775 per cent increase over the Company’s current 4,000 kg DFE extraction capacity. The Company expects that Paris can through-put all dried flower grown by Aleafia Health, including at its newly expanded, 86-acre Port Perry Outdoor Grow site.

To complete the final stage of securing its required Licence Amendment, the Company’s wholly-owned subsidiary, Emblem Cannabis Corp., expects to submit its final evidence package to Health Canada this October, demonstrating the facility’s operational readiness.

PURPOSE-BUILT TO EU-GMP STANDARDS FOR EXPORT TO EU MARKET

The facility is purpose-built to meet European Union Good Manufacturing Practices (“EU-GMP”) certification requirements. EU-GMP certified facilities demonstrate the highest level of pharmaceutical-grade quality, and securing the certification will allow Aleafia Health to begin exporting finished goods including cannabis oils and capsules to the EU.

Through the Aleafia Health Germany joint-venture with German pharmaceutical wholesaler and logistics company Acnos Pharma GmbH, Aleafia will gain access to the burgeoning German medical cannabis market, with access to 22,000 pharmacies and 110 distribution centres.

115,000 KG EXTRACTION CAPACITY WITH ABILITY FOR FURTHER EXPANSION

The Paris expansion will rapidly accelerate Aleafia Health’s production capacity, and ability to create a wide variety of differentiated products across multiple categories. It has been built specifically to allow for further, significant expansions of extraction capacity by utilizing additional machinery. For instance, the existing capital expenditures budget accounts for additional ethanol extraction machinery that would bring total capacity to 190,000 kg DFE and would take approximately eight weeks to bring online.

Each element of the extraction and production process occupies a purpose-built, dedicated room in the facility, maximizing through-put ability and operational efficiency. Highlights include:

  • 40,000 kg DFE of supercritical C02 extraction which is primarily used for the production of pharmaceutical-grade oil-based products including capsules and sprays
  • 75,000 kg DFE of ethanol extraction, which produces a tasteless distillate ideally suited for new product formats including edibles, beverages and extracts
  • In-house analytical testing and quality assurance equipment, allowing for products to reach market two to three weeks earlier than with the use of external third-party testing
  • Production and packaging machinery along with space dedicated to creating new, differentiated product formats soon available in the Canadian market
  • A dedicated laboratory for ongoing R&D, product development and continued process optimization
  • A logistics centre handling order fulfilment to medical patients, provincial wholesalers and all international exports
  • The entire expansion project, including machinery for yet to be announced new product formats, falls within the Company’s fully funded, previously reported capital expenditures budget

“The Paris expansion represents the crown jewel of Aleafia Health’s cannabis ecosystem. This facility will allow us to rapidly expand the production of high-margin derivative products, while adding new, differentiated formats that are grown, processed, packaged and exported by Aleafia Health,” said CEO Geoffrey Benic. “We look forward to bringing the next generation of cannabis products to market, while greatly expanding our international footprint in Germany, Australia and beyond.”

For Investor and Media Relations, please contact:

Nicholas Bergamini, VP Investor Relations
1-833-TSX-ALEF (879-2533)
IR@AleafiaHealth.com
LEARN MORE: www.AleafiaHealth.com

About Aleafia Health:

Aleafia Health is a leading, vertically integrated cannabis health and wellness company with four primary business units: Cannabis Cultivation & Products, Health & Wellness Clinics, Cannabis Education, and Consumer Experience with ecommerce, retail distribution and provincial supply agreements.

Aleafia Health owns three major cannabis product & cultivation facilities, two of which are licensed and operational including the first large-scale, operational outdoor cultivation facility in Canadian history. The Company produces a diverse portfolio of commercially proven, high-margin derivative products including oils, capsules and sprays. Aleafia Health operates the largest national network of medical cannabis clinics and education centres staffed by MDs, nurse practitioners and educators and has international operations in three continents.

Innovation is at the heart of Aleafia Health competitive advantage. The Company maintains a medical cannabis dataset with over 10 million data points to inform proprietary illness-specific product development and its highly differentiated education platform FoliEdge Academy. The Company is committed to creating sustainable shareholder value and has been named the 2019 top performing company of the year by the TSX Venture Exchange prior to graduation to the TSX.

Forward Looking Information

This news release contains forward-looking information within the meaning of applicable Canadian and United States securities laws. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including risks contained in the Company’s annual information form filed with Canadian securities regulators available on the Company’s SEDAR profile at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company does not undertake any obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Primary Logo

Published at Mon, 07 Oct 2019 11:03:09 +0000

CEO Of Kona Gold Solutions Inc (OTCMKTS:KGKG) Unveils Kona Pink Hemp Energy Drink in 12.0 oz Can

CEO Of Kona Gold Solutions Inc (OTCMKTS:KGKG) Unveils Kona Pink Hemp Energy Drink in 12.0 oz Can

Kona
Gold Solutions Inc (OTCMKTS:KGKG)
has announced the launch of Kona Pink
Hemp Energy Drink in 12.0 oz cans. The company entered a pact with a non-profit
organization – American Breast Cancer Foundation (ABCF), which developed a
beautiful 12.0 oz can for the new energy drink. Kona Gold will donate a portion
of the sales of new energy drinks to ABCF to help support awareness about
breast cancer, screening, and support services. Undeserved and uninsured
individuals would benefit from the financial support of Kona Gold for breast
cancer treatment.

Launch
in the breast cancer awareness month

The launch perfectly coincides with
the breast cancer awareness month – October. The customers can purchase Kona
Pink Hemp Energy drinks from its website and also from Amazon’s online store.
Kona Gold already started shipping the energy drinks to its distributors. The
company will take part in various events related to improving awareness about
breast cancer in October.

Chief Executive Officer of Kona Gold,
Robert Clark, is pleased to introduce a new hemp energy drink, which is
developed using pink grapefruit flavor. He said the consumers would be
enthralled with the tasty Hemp energy drink in a beautifully designed 12.0 oz
can. The company is fortunate to associate with a non-profit organization –
ABCF and take part in a breast cancer awareness campaign. It is also exciting
to provide financial support to ABCF to treat uninsured breast cancer patients.

Appoints
Director (National Sales)

Kona Gold has announced the
appointment of Director (National Sales) and Chief Financial Officer. Paul
O’Renick, Director (National Sales), and Lori Radcliffe, CFO, will join the
company on October 1 and October 8, respectively. After experiencing excellent
sales growth in 2019, Kona Gold filled the new vital positions to augment its
growth further.

Kona
Gold introduces Storm CBD Water

Kona Gold introduced Storm CBD Water
across the nation as part of its expansion in the CBD beverage market. High
Alkaline water – Storm CBD is available in 1-liter bullet bottles, and each
comprises 20 mg of Cannabidiol isolate. It has started shipping Storm CBD to
its existing distribution channels in the US. The consumers can buy Storm CBD
water from its HighDrate website.

Published at Mon, 07 Oct 2019 12:05:21 +0000

Pasha Brands Announces Acquisition of Premium Extracts Brand Beard Brothers Collective

Pasha Brands Announces Acquisition of Premium Extracts Brand Beard Brothers Collective

Pasha Brands Ltd. (“Pasha“) (CSE: CRFT) (CSE: CRFT.CN) (OTC: CRFTF) (FSE: ZZD), Canada’s largest craft cannabis brands organization, has announced the acquisition of the Beard Brothers Collective brand. Beard Brothers was previously used by an established provider of craft cannabis concentrates, extracts, tinctures, oils, flower, topicals, edibles, rosin, distillate, and isolates, based in Victoria, BC.

Founded in 2014 by brother-and-sister duo Bradley and Elissa Macauley, the Beard Brothers brand was previously associated with a non-profit, medicinal cannabis provider. Having worked closely with physicians and experts in cannabis therapy for years, the Macauley’s were dedicated to providing consumers access to quality products that met their needs. The Macauley’s award-winning concentrates and advanced extraction technologies have been lauded by manufacturers and consumers alike. Pasha hopes to make products available under the Beard Brothers through legal retailers across Canada after October 17, 2019.

“The Beard Brothers brand feels right at home with Pasha, helping to shape the new cannabis movement,” said cofounder Bradley Macauley, reacting to the news. “Elissa and I truly feel blessed to be able to share our love for this sacred plant with our communities and the world, and we’re grateful our products will reach more people thanks to Pasha.”

Pasha has acquired all of Beard Brothers Collectives’ trademarks, names, and intellectual property and will launch the brand in the Canadian regulated market in the coming months. Already, Beard Brothers Collective products have been included in several product offering packages presented to provincial wholesalers, including Ontario and British Columbia.

“Adding an established brand like Beard Brothers to our family of craft cultivators and purveyors shows that Pasha is setting the bar for craft products in all areas, including extracts and concentrates,” said Patrick Brauckmann, Executive Chairman of Pasha Brands. “Bradley and Elissa have truly captured the essence of craft, both with their premium products and their patient-first model. We’re committed to upholding that dedication as we prepare to provide Canadian cannabis consumers with access to these fantastic products.”

Pasha is also pleased to announce the appointment of senior Vice-President of Southern Glazier’s Wine and Spirits Doug Wieland to it’s Board of Directors. As a new member of the Board, Doug will join fellow directors Patrick Brauckmann, Rosy Mondin, Scott Walters, and Hugo Alves. Wieland has spent over a decade working in beverage alcohol distribution in Canada, the majority of that time at Southern Glazer’s Wine & Spirits, the world’s largest distributor of beverage alcohol. Earlier this year, he oversaw the launch of a wine division focused on growing the company’s business across the Canadian market.

In July, Pasha signed an agreement with Great North, a company established by the owners of Southern Glazer’s and Canada’s first national sales broker for legalized adult-use cannabis, to distribute Pasha’s craft cannabis products throughout Canada. The agreement will give Pasha access to Great North’s nationwide sales and distribution network, which includes experienced sales and marketing teams, established relationships with all government cannabis distribution boards, as well as coverage with Canada’s numerous private retailers.

“Having spent the past year meeting the Pasha team and craft producers in BC Craft’s supply chain, we believe that the next big move in Canada’s cannabis sector will be craft products,” Wieland said at the time. “I am thrilled to be joining Pasha’s Board just as Canada’s legal cannabis market prepares to usher in a new wave of consumer products.”

“Doug’s skillset lends itself perfectly to our operational plan at Pasha,” said Executive Director Patrick Brauckmann in reaction to the news. “His experience at the head of one of the world’s largest beverage alcohol distributors is an incredible asset to us, and I’m very much looking forward to working alongside him as we look to make Pasha the world’s most recognized craft cannabis brand.”

About Pasha Brands

Based in Vancouver, British Columbia, Pasha is a vertically integrated, prohibition-era brand house firmly rooted in BC’s craft cannabis industry, which boasts an international reputation. With proven capabilities in cannabis cultivation, genetic research and development, product processing, and retail, Pasha is uniquely positioned in the new legal cannabis market through its network of hundreds of craft cannabis suppliers under the Pasha umbrella.

Pasha subsidiary, Medcann Health Products Ltd., is a Health Canada licensed cultivator and processor with a licence to sell medical cannabis products in Canada.

Pasha and BC Craft are also developing a craft cannabis campus, which is dedicated to bringing craft quality into the newly legal cannabis market in Canada. BC Craft is driven to assist craft growers in obtaining security clearance and licensing to grow as micro-cultivators, specializing in education and compliance to bring growers into the regulated cannabis supply market.

Pasha’s common shares trade on the CSE under the symbol “CRFT” and on the FSE under the symbol “ZZD”.

For more information, please visit www.pashabrands.com.

Media & Investor Relations Contact

Emerald Asuncion
communications@pashabrands.com
(236)521-5135

Published at Fri, 04 Oct 2019 12:30:23 +0000